Generic Drugs
Current Products
Injections
| MOLECULE | CATEGORY | PACK |
|---|---|---|
| Ceftriaxone-250 mg | Injection | VIAL |
| Ceftriaxone-500 mg | Injection | VIAL |
| Ceftriaxone-1000 mg | Injection | VIAL |
| Ceftriaxone 1000 + Sulbactum 500 mg | Injection | VIAL |
| Ceftriaxone 1000 + Sulbactum 125 mg | Injection | VIAL |
| Diclofenac Sodium-75 mg/ml | Ampoule | 1 ml tray pack |
| Alprostadil | Injection | VIAL |
| Amikacin-100 mg | Injection | VIAL |
| Amikacin-250 mg | Injection | VIAL |
| Amikacin-500 mg | Injection | VIAL |
| Mecobalamine 1000mcg + Vit B1, B6 Nicotinamide & D-Panthenol | Injection | AMPOULE Blister pack |
| Alpha-Beta Arteether-150mg | Injection | AMPOULE |
| Tramadol 100 mg | AMPOULE | 2 ml |
| Onden Setron 2 mg | Injection | AMPOULE |
Eye/Ear Drops
| MOLECULE | CATEGORY | PACK |
|---|---|---|
| Ofloxacin | Drops | 10 ml |
| Ofloxacin+ Dexamethasone | Drops | 10 ml |
| Latanoprost | Drops | 2.5 ml |
Capsules
| MOLECULE | CATEGORY | PACK |
|---|---|---|
| Amoxycillin-250+Dicloxacillin 250mg | CAPS | 10×10 |
| Amoxycillin-500 mg | CAPS | 10×10 |
| Amoxycillin-250 mg | CAPS | 5x3x10 |
| Bromhexine+CPM+Para+ Guai | CAPS | 20×10 |
| Omeprazole-20 mg | CAPS | 10×10 |
| Omeprazole-20 mg Domperidone-10 mg | CAPS | 10×10 |
| Rabeprazole 20+Domperidone SR 30mg | CAPS | 10×10 |
| Cephalexin 500 mg | CAPS | 10×10 |
Tablets
| MOLECULE | CATEGORY | PACK |
|---|---|---|
| Pantoprazole-40 mg | TABS | 5x2x10 |
| Pantoprazole 40 mg Domperidone 10 mg | TABS | 10×10 |
| Misoprostol 600 mcg | TABS | 1×10 |
| Mifepristone 200 mcg+ Misoprostol 400 mcg | TABS | 2×10 |
| Rabeprazole 20 mg | TABS | 10×10 |
| Rabeprazole 20 mg + Domperidone 10 mg | TABS | 10×10 |
Upcoming Products
Gulzaar is developing affordable generic drug products in the pediatric, men’s health, and women’s health areas. Its generic-drug portfolio consists of numerous product targets across a wide range of therapeutic areas that are the therapeutic equivalent of their brand-name counterparts.
Autoimmune, neurodegenerative, oncology, chronic pain, and infectious disease are examples of the therapeutic areas in which Gulzaar will provide generic options to patients. Although some targeted opportunities represent significant barriers to entry, Gulzaar’s professionals have a proven track record that will enable them to handle the technical and regulatory challenges that generic entry presents.
Currently, Gulzaar Pharma is focused on commercializing generic medicines for the treatment of constipation and IBS indications. Gulzaar is also targeting generic drugs for the treatment of autoimmune disorders such as arthritis, psoriasis, diabetes, and multiple sclerosis.
In addition, the Gulzaar Animal Health™ division of Gulzaar will deliver affordable animal drugs to consumers. Gulzaar Animal Health™ is particularly focused on providing generic alternatives to branded drugs for companion animals such as dogs and cats. Antibacterial, antihelmintic, and antiparasitic therapeutics will provide consumers with cheaper alternatives to their more expensive branded counterparts.